- H J M Vrijhoef, research fellowa (b.vrijhoef@zw.unimaas.nl),
- C Spreeuwenberg, professora,
- I M J G Eijkelberg, research fellowb,
- B H R Wolffenbuttel, associate professorc,
- G G van Merode, associate professorb
- a Department of Health Care Studies, Faculty of Health Sciences, University of Maastricht, PO Box 616, 6200 MD Maastricht, Netherlands
- b Department of Health Organisation, Policy and Economics, Faculty of Health Sciences, University of Maastricht, PO Box 616, 6200 MD Maastricht, Netherlands
- c Department of Endocrinology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
- Correspondence to: H J M Vrijhoef
- Accepted 5 September 2001
Chronic diseases and associated conditions will always pose a challenge to healthcare systems. New healthcare models are being introduced in Western countries in response to a set of problems that are evident to some degree in all health services—for example, uncoordinated arrangements for delivering care, bias towards acute treatment, neglect of preventive care, and inappropriate treatment.1 These models take account of the pressure on quality and costs of chronic care and originate from the overlapping approaches of integrated care (United States) and shared care (western Europe). 2 3 In the Netherlands, shared care models have acted as a precursor of the recently introduced concept of disease management. Although several disease management initiatives are emerging, the model is not being adopted as fast as might be expected from the benefits that are claimed to result from it.4 In this article we describe the process of moving from a shared care model to a disease management model by considering recent developments in diabetes care in the region of Maastricht. We also describe the use of health technology assessment to evaluate the model.
Summary points
The concepts of integrated care and shared care can be regarded, in the Netherlands at least, as the precursor of disease management
Implementation of a shared care model for diabetes in the region of Maastricht ensured that necessary conditions were met for a disease management model
Widespread use of disease management models is hampered by lack of evidence
Evidence from health technology assessment is necessary to justify large scale use of disease management models but will not be sufficient by itself
Shared diabetes care in Maastricht region
Shared care for patients with stable diabetes mellitus type 2 who were receiving care from an endocrinologist in an outpatient clinic was implemented in the region of Maastricht in 1997. Two changes were made from usual care: …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012